1. Intra-assay Repeatability of the Newly Developed Assay.
| Virus Type | Average copies (μL) | SD | CV% | |
|---|---|---|---|---|
| SARS-CoV-2 N1 | CAL1 | 66.3 | 4.78 | 7.18 |
| CAL2 | 5.80 | 1.12 | 7.18 | |
| CAL3 | 0.55 | 0.25 | 46.1 | |
| SARS-CoV-2 N2 | CAL1 | 69.56 | 4.71 | 6.77 |
| CAL2 | 6.08 | 1.18 | 19.5 | |
| CAL3 | 0.50 | 0.21 | 41.7 | |
| IAV | CAL1 | 40.21 | 2.71 | 6.75 |
| CAL2 | 3.46 | 0.80 | 23.2 | |
| CAL3 | 0.36 | 0.16 | 43.7 | |
| IBV | CAL1 | 72.79 | 4.05 | 5.57 |
| CAL2 | 5.45 | 0.69 | 12.6 | |
| CAL3 | 0.51 | 0.20 | 38.1 | |
| RSV | CAL1 | 69.94 | 3.10 | 4.43 |
| CAL2 | 5.89 | 0.52 | 8.87 | |
| CAL3 | 0.72 | 0.22 | 31.1 | |
| HAV | CAL1 | 63.29 | 3.01 | 4.75 |
| CAL2 | 6.14 | 0.83 | 13.5 | |
| CAL3 | 0.45 | 0.18 | 40.8 | |
| HEV | CAL1 | 66.90 | 2.96 | 4.42 |
| CAL2 | 4.61 | 0.45 | 9.84 | |
| CAL3 | 0.48 | 0.15 | 31.4 |